View in EDS HTML Full Text PDF Full Text

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.

Saved in:
Bibliographic Details
Title: Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
Authors: Jain N; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hartert K; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Tadros S; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Fiskus W; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Havranek O; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ma MCJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bouska A; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Heavican T; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Kumar D; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Deng Q; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Moore D; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Pak C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Liu CL; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Gentles AJ; Department of Radiology, Stanford University, Stanford, CA 94305, USA., Hartmann E; Institute of Pathology, University of Würzburg, Würzburg 97080, Germany.; Comprehensive Cancer Center Mainfranken, Wurzburg 97080, Germany., Kridel R; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G 2C4, Canada., Smedby KE; Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Juliusson G; Department of Laboratory Medicine, Stem Cell Center, Lund University, Lund SE-221 00, Sweden., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Universitetssjukhuset, Stockholm SE-171 76, Sweden., Gascoyne RD; Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg 97080, Germany.; Comprehensive Cancer Center Mainfranken, Wurzburg 97080, Germany., Giancotti F; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Neelapu SS; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Westin J; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vose JM; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Lunning MA; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA., Greiner T; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Rodig S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Iqbal J; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Davis RE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bhalla K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Green MR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. mgreen5@mdanderson.org.; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Source: Science translational medicine [Sci Transl Med] 2019 Jun 19; Vol. 11 (497).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31217338
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jain+N%22">Jain N</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Hartert+K%22">Hartert K</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Tadros+S%22">Tadros S</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Fiskus+W%22">Fiskus W</searchLink>; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Havranek+O%22">Havranek O</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Ma+MCJ%22">Ma MCJ</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Bouska+A%22">Bouska A</searchLink>; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Heavican+T%22">Heavican T</searchLink>; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+D%22">Kumar D</searchLink>; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Deng+Q%22">Deng Q</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Moore+D%22">Moore D</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Pak+C%22">Pak C</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Liu+CL%22">Liu CL</searchLink>; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Gentles+AJ%22">Gentles AJ</searchLink>; Department of Radiology, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hartmann+E%22">Hartmann E</searchLink>; Institute of Pathology, University of Würzburg, Würzburg 97080, Germany.; Comprehensive Cancer Center Mainfranken, Wurzburg 97080, Germany.<br /><searchLink fieldCode="AU" term="%22Kridel+R%22">Kridel R</searchLink>; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G 2C4, Canada.<br /><searchLink fieldCode="AU" term="%22Smedby+KE%22">Smedby KE</searchLink>; Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Juliusson+G%22">Juliusson G</searchLink>; Department of Laboratory Medicine, Stem Cell Center, Lund University, Lund SE-221 00, Sweden.<br /><searchLink fieldCode="AU" term="%22Rosenquist+R%22">Rosenquist R</searchLink>; Department of Molecular Medicine and Surgery, Karolinska Universitetssjukhuset, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Gascoyne+RD%22">Gascoyne RD</searchLink>; Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.<br /><searchLink fieldCode="AU" term="%22Rosenwald+A%22">Rosenwald A</searchLink>; Institute of Pathology, University of Würzburg, Würzburg 97080, Germany.; Comprehensive Cancer Center Mainfranken, Wurzburg 97080, Germany.<br /><searchLink fieldCode="AU" term="%22Giancotti+F%22">Giancotti F</searchLink>; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Neelapu+SS%22">Neelapu SS</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Westin+J%22">Westin J</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Vose+JM%22">Vose JM</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Lunning+MA%22">Lunning MA</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Greiner+T%22">Greiner T</searchLink>; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Rodig+S%22">Rodig S</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Iqbal+J%22">Iqbal J</searchLink>; Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.<br /><searchLink fieldCode="AU" term="%22Alizadeh+AA%22">Alizadeh AA</searchLink>; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Davis+RE%22">Davis RE</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Bhalla+K%22">Bhalla K</searchLink>; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Green+MR%22">Green MR</searchLink>; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. mgreen5@mdanderson.org.; Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2019 Jun 19; Vol. 11 (497).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31217338
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/scitranslmed.aav5599
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jain N
      – PersonEntity:
          Name:
            NameFull: Hartert K
      – PersonEntity:
          Name:
            NameFull: Tadros S
      – PersonEntity:
          Name:
            NameFull: Fiskus W
      – PersonEntity:
          Name:
            NameFull: Havranek O
      – PersonEntity:
          Name:
            NameFull: Ma MCJ
      – PersonEntity:
          Name:
            NameFull: Bouska A
      – PersonEntity:
          Name:
            NameFull: Heavican T
      – PersonEntity:
          Name:
            NameFull: Kumar D
      – PersonEntity:
          Name:
            NameFull: Deng Q
      – PersonEntity:
          Name:
            NameFull: Moore D
      – PersonEntity:
          Name:
            NameFull: Pak C
      – PersonEntity:
          Name:
            NameFull: Liu CL
      – PersonEntity:
          Name:
            NameFull: Gentles AJ
      – PersonEntity:
          Name:
            NameFull: Hartmann E
      – PersonEntity:
          Name:
            NameFull: Kridel R
      – PersonEntity:
          Name:
            NameFull: Smedby KE
      – PersonEntity:
          Name:
            NameFull: Juliusson G
      – PersonEntity:
          Name:
            NameFull: Rosenquist R
      – PersonEntity:
          Name:
            NameFull: Gascoyne RD
      – PersonEntity:
          Name:
            NameFull: Rosenwald A
      – PersonEntity:
          Name:
            NameFull: Giancotti F
      – PersonEntity:
          Name:
            NameFull: Neelapu SS
      – PersonEntity:
          Name:
            NameFull: Westin J
      – PersonEntity:
          Name:
            NameFull: Vose JM
      – PersonEntity:
          Name:
            NameFull: Lunning MA
      – PersonEntity:
          Name:
            NameFull: Greiner T
      – PersonEntity:
          Name:
            NameFull: Rodig S
      – PersonEntity:
          Name:
            NameFull: Iqbal J
      – PersonEntity:
          Name:
            NameFull: Alizadeh AA
      – PersonEntity:
          Name:
            NameFull: Davis RE
      – PersonEntity:
          Name:
            NameFull: Bhalla K
      – PersonEntity:
          Name:
            NameFull: Green MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2019 Jun 19
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1946-6242
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 497
          Titles:
            – TitleFull: Science translational medicine
              Type: main
ResultId 1